Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 792

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 792
---
 earlier of December 31, 2024, or a liquidity event with a strategic partner, as amended on March 18, 2024. In October 2024, the Company entered into debt forgiveness agreements with the holders of the related party short -termloans, pursuant to which the Company issued an aggregate of 290,518common shares, par value CHF 0.03per share, or the common shares, of the Company, at a conversion price of $ 5.65(rounded) per share, in full satisfaction of an

Annex F-16 NLS PHARMACEUTICS LTD. AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

aggregate amount of CHF 1,492,431($ 1,640,034) in loans and interest provided to the Company by the Lenders, or collectively, the Loans. This conversion was facilitated through an ordinary capital increase, providing the necessary shares for the debt holders, and was recorded at fair market value with no gain or loss recognized in the statement of operations.

Note 6

Other Accrued Liabilities:

The Company’s other accrued liabilities consisted of the following as of December 31, 2024 and 2023:

|                                        |     | December 31, |    2024 |     |   |      2023 |
|:---------------------------------------|:----|:-------------|--------:|:----|:--|----------:|
| Professional consultants’ expenses     |     | $            | 110,345 |     | $ |   332,690 |
| Vendor liabilities                     |     |              |       — |     |   |   112,635 |
| Stamp tax                              |     |              | 125,793 |     |   |         — |
| Related party interest short term loan |     |              |       — |     |   |    25,605 |
| Accrued Board of Directors fees        |     |              |  47,586 |     |   |   184,672 |
| Accrued bonus                          |     |              |       — |     |   |   960,025 |
| Other accrued expenses                 |     |              |  27,554 |     |   |    36,643 |
| Total other accrued liabilities        |     | $            | 311,278 |     | $ | 1,652,270 |

Note 7 Deferred Re